Long-Term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy
Journal article, Peer reviewed
MetadataShow full item record
Original versionNeurology: Neuroimmunology and neuroinflammation. 2017, 4 (5). 10.1212/NXI.0000000000000389
We previously described the possible clinical effects of early monotherapeutic IV-immunomodulation (IVIg) treatment in sporadic1 but not in postH1N1 vaccination narcolepsy type 1 (NT1).2 We report here an early post-H1N1 vaccination NT1 case treated with combined immunomodulation of IVIg and methylprednisolone, and a comparable sporadic NT1 case.